Study on the Risk Factors for Hyperuricaemia and Related Vascular Complications in Patients with Type 2 Diabetes Mellitus

References

• IDF. Available from: http://www.idf.org/. Accessed 820, 2020.
   Google Scholar
• Huang YY, Fan WJ, Zhu JJ, Zhan L, Chen W. DB1 epidemiology, treatment and economic burden of type 2 diabetes mellitus with nephropathy complications in China. Value Health. 2012;15(7):A603–A603. doi:10.1016/j.jval.2012.08.013
   Web of Science ®Google Scholar
• Dal Canto E, Ceriello A, Ryden L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2_SUPPL):25–32. doi:10.1177/204748731987837131722562
   PubMed Web of Science ®Google Scholar
• Xiao H, Du AM, Yun P, Zhang HF, Tian Y, Xiao FX. Prevalence and risk factors of chronic complications of type 2 diabetic inpatients in Hubei Province of central China: results from a multiple-hospital study. Int J Diabetes Dev Ctries. 2016;36(2):242–247. doi:10.1007/s13410-015-0452-7
   Web of Science ®Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:19. doi:10.1186/s12933-018-0728-629368650
   PubMed Web of Science ®Google Scholar
• Aldemir O, Turgut F, Gokce C. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease. Ren Fail. 2017;39(1):597–601. doi:10.1080/0886022X.2017.135818028805547
   PubMed Web of Science ®Google Scholar
• Kute VB, Godara SM, Shah PR, et al. Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country. Int Urol Nephrol. 2012;44(1):269–274. doi:10.1007/s11255-011-0040-921805084
   PubMed Web of Science ®Google Scholar
• Kainz A, Hronsky M, Stel VS, et al. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant. 2015;30:113–118. doi:10.1093/ndt/gfv073
   Web of Science ®Google Scholar
• Abougalambou SSI, Abougalambou AS. Prevalence and risk factors of microalbuminuria in type 2 diabetes mellitus outpatients at University Sains Malaysia Hospital. Diabetes Metab Syndr. 2013;7(2):64–67. doi:10.1016/j.dsx.2013.02.03423680242
   PubMedGoogle Scholar
• Svensson MK, Tyrberg M, Nystrom L, et al. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors. Diabetes Metab Res Rev. 2015;31(2):138–146. doi:10.1002/dmrr.257425044633
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308. doi:10.1681/ASN.201207071823362314
   PubMed Web of Science ®Google Scholar
• Rostamkhani H, Mellati AA, Tabaei BS, Alavi M, Mousavi SN. Association of serum zinc and vitamin A levels with severity of retinopathy in type 2 diabetic patients: a cross-sectional study. Biol Trace Elem Res. 2019;192(2):123–128. doi:10.1007/s12011-019-01664-z30790120
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Li L, et al. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy. Ren Fail. 2018;40(1):243–251. doi:10.1080/0886022X.2018.145645329633887
   PubMed Web of Science ®Google Scholar
• Li W, Xie B, Qiu S, et al. Non-lab and semi-lab algorithms for screening undiagnosed diabetes: a cross-sectional study. Ebiomedicine. 2018;35:307–316. doi:10.1016/j.ebiom.2018.08.00930115607
   PubMed Web of Science ®Google Scholar
• Arboix A, Rivas A, Garcia-Eroles L, de Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 2005;5:9. doi:10.1186/1471-2377-5-915833108
   PubMed Web of Science ®Google Scholar
• Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death - a population-based study of 13000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164(13):1422–1426. doi:10.1001/archinte.164.13.142215249351
   PubMedGoogle Scholar
• Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes - the nurses’ health study. Diabetes Care. 2007;30(7):1730–1735. doi:10.2337/dc06-236317389335
   PubMed Web of Science ®Google Scholar
• Zhang XD, Chen YR, Ge L, Ge ZM, Zhang YH. Features of stroke in Chinese diabetes patients: a hospital-based study. J Int Med Res. 2007;35(4):540–546. doi:10.1177/14732300070350041417697532
   PubMed Web of Science ®Google Scholar
• Gujjar AR. Diabetes and Stroke: more than just accelerated atherosclerosis? Sultan Qaboos Univ Med J. 2018;18(3):e261–e263. doi:10.18295/squmj.2018.18.03.00130607264
   PubMedGoogle Scholar
• Murea M. Advanced kidney failure and hyperuricemia. Adv Chronic Kidney Dis. 2012;19(6):419–424. doi:10.1053/j.ackd.2012.07.00823089278
   PubMed Web of Science ®Google Scholar
• Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr. 2010;2. doi:10.1186/1758-5996-2-24
   Web of Science ®Google Scholar
• Lai SW, Tan CK, Ng KC. Epidemiology of hyperglycemia in elderly persons. J Gerontol Ser a Biol Sci Med Sci. 2000;55(5):M257–M259. doi:10.1093/gerona/55.5.M25710819314
   PubMed Web of Science ®Google Scholar
• Li Y, Fan X, Li C, et al. The relationships among hyperuricemia, body mass index and impaired renal function in type 2 diabetic patients. Endocr J. 2018;65(3):281–290.29237999
   PubMed Web of Science ®Google Scholar
• Kanbay M, Segal M, Afsar B, Kang D-H, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99(11):759–766. doi:10.1136/heartjnl-2012-30253523343689
   PubMed Web of Science ®Google Scholar
• Liang -C-C, Lin P-C, Lee M-Y, et al. Association of serum uric acid concentration with diabetic retinopathy and albuminuria in taiwanese patients with type 2 diabetes mellitus. Int J Mol Sci. 2016;17(8):1248. doi:10.3390/ijms17081248
   PubMed Web of Science ®Google Scholar
• Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012;35(1):99–104. doi:10.2337/dc11-134622028277
   PubMed Web of Science ®Google Scholar
• Bartakova V, Kuricova K, Pacal L, et al. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus. J Diabetes Complications. 2016;30(7):1300–1307. doi:10.1016/j.jdiacomp.2016.06.00227324705
   PubMed Web of Science ®Google Scholar
• Yan Z-P, Ma J-X. Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(8):1194–1199. doi:10.18240/ijo.2016.08.1727588275
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Ophthalmology. 1991;98(5):807–822. doi:10.1016/S0161-6420(13)38013-02062514
   PubMed Web of Science ®Google Scholar
•  American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2000; 23 Suppl 1: S69-72.PMID: 12017684.
   Google Scholar
• Wang H, Zhang L, Liu Z, et al. Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–1765. doi:10.2147/PPA.S15929330237698
   PubMed Web of Science ®Google Scholar
• Gaita L, Timar R, Lupascu N, et al. The impact of hyperuricemia on cardiometabolic risk factors in patients with diabetes mellitus: a cross-sectional study. Diabetes Metab Syndr Obes. 2019;12:2003–2010. doi:10.2147/DMSO.S22257031632111
   PubMed Web of Science ®Google Scholar
• Cibickova L, Langova K, Vaverkova H, Kubickova V, Karasek D. Correlation of uric acid levels and parameters of metabolic syndrome. Physiol Res. 2017;66(3):481–487. doi:10.33549/physiolres.93341028248530
   PubMed Web of Science ®Google Scholar
• Zhu C, Cui R, Gao M, et al. The associations of serum uric acid with obesity-related acanthosis nigricans and related metabolic indices. Int J Endocrinol. 2017;2017:1–9. doi:10.1155/2017/5438157
   Web of Science ®Google Scholar
• de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4. doi:10.1186/1758-5996-4-12
   Web of Science ®Google Scholar
• Cohen E, Fraser A, Goldberg E, Milo G, Garty M, Krause I. Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel. Nephrol Dial Transplant. 2013;28:130–135. doi:10.1093/ndt/gft072
   Web of Science ®Google Scholar
• Wei F, Chang B, Yang X, Wang Y, Chen L, Li W-D. Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 diabetes. Sci Rep. 2016;6:1–9.28442746
   PubMed Web of Science ®Google Scholar
• Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288–298. doi:10.1111/j.1463-1326.2009.01160.x20380649
   PubMed Web of Science ®Google Scholar
• Chen W-Z, Hung -C-C, Wen Y-W, Ning H-C, Gau B-R, Huang -Y-Y. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria. Ren Fail. 2014;36(2):171–175. doi:10.3109/0886022X.2013.83231224028605
   PubMed Web of Science ®Google Scholar
• Garg N, Moorthy N, Kapoor A, et al. Hemoglobin A(1c) in nondiabetic patients: an independent predictor of coronary artery disease and its severity. Mayo Clin Proc. 2014;89(7):908–916. doi:10.1016/j.mayocp.2014.03.01724996234
   PubMed Web of Science ®Google Scholar
• Hou Y-L, Yang X-L, Wang C-X, Zhi L-X, Yang M-J, You C-G. Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents. Lipids Health Dis. 2019;18. doi:10.1186/s12944-019-1031-6
   Web of Science ®Google Scholar
• Cui N, Cui J, Sun J, et al. Triglycerides and total cholesterol concentrations in association with hyperuricemia in Chinese adults in Qingdao, China. Risk Manag Healthc Policy. 2020;13:165–173. doi:10.2147/RMHP.S24338132184687
   PubMed Web of Science ®Google Scholar
• Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabol Clin Exp. 1998;47(8):929–933. doi:10.1016/S0026-0495(98)90346-8
   PubMed Web of Science ®Google Scholar
• Zhang X, Meng Q, Feng J, et al. The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China. Lipids Health Dis. 2018;17. doi:10.1186/s12944-018-0882-6
   Web of Science ®Google Scholar
• Xu J, Peng H, Ma Q, et al. Associations of non-high density lipoprotein cholesterol and traditional blood lipid profiles with hyperuricemia among middle-aged and elderly Chinese people: a community-based cross-sectional study. Lipids Health Dis. 2014;13(1):117. doi:10.1186/1476-511X-13-11725052552
   PubMed Web of Science ®Google Scholar
• Mahwish UN, Ponnaluri KC, Heera B, et al. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: a case-control study from Hyderabad, India. Indian J Nephrol. 2020;30(2):77–84. doi:10.4103/ijn.IJN_244_1832269430
   PubMed Web of Science ®Google Scholar
• Song Y, Liu W, Tang K, Zang J, Li D, Gao H. Mangiferin alleviates renal interstitial fibrosis in streptozotocin-induced diabetic mice through regulating the PTEN/PI3K/Akt signaling pathway. J Diabetes Res. 2020;2020.
   Web of Science ®Google Scholar
• Hu X, Zhuang X-D, Mei W-Y, et al. Exploring the causal pathway from body mass index to coronary heart disease: a network Mendelian randomization study. Ther Adv Chronic Dis. 2020;11:204062232090904. doi:10.1177/2040622320909040
   Web of Science ®Google Scholar
• Wu D, Liu H, Li S-H. Association of elevated uric acid with metabolic disorders and analysis of the risk factors of hyperuricemia in type 2 diabetes mellitus. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(3):544–547.21421503
   PubMedGoogle Scholar
• Dong X, Zhang H, Wang F, et al. Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: the Henan rural cohort study. Mod Rheumatol. 2019;1–11. doi:10.1080/14397595.2019.1660048
   Web of Science ®Google Scholar
• Crass RL, Pai MP. Estimating renal function in drug development: time to take the fork in the road. J Clin Pharmacol. 2019;59(2):159–167. doi:10.1002/jcph.131430184267
   PubMed Web of Science ®Google Scholar
• Wagner M, Wanner C, Schich M, et al. Patient’s and physician’s awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey. BMC Nephrol. 2017;18. doi:10.1186/s12882-017-0730-3
   Web of Science ®Google Scholar
• Petrovic S, Bogavac-Stanojevic N, Lakic D, et al. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Biochemi Medica. 2015;25(2):262–271. doi:10.11613/BM.2015.027
   PubMed Web of Science ®Google Scholar
• Qi D, Liu J, Wang C, et al. Sex-specific differences in the prevalence of and risk factors for hyperuricemia among a low-income population in China: a cross-sectional study. Postgrad Med. 2020;1–9. doi:10.1080/00325481.2020.1761133
   Web of Science ®Google Scholar
• Ni Q, Lu X, Chen C, Du H, Zhang R. Risk factors for the development of hyperuricemia A STROBE-compliant cross-sectional and longitudinal study. Medicine. 2019;98(42):e17597. doi:10.1097/MD.000000000001759731626136
   PubMed Web of Science ®Google Scholar
• Maeda H, Michiue T, Zhu B-L, et al. Potential risk factors for sudden cardiac death: an analysis of medicolegal autopsy cases. Leg Med (Tokyo). 2009;11(Suppl 1):S263–265. doi:10.1016/j.legalmed.2009.01.00419254862
   PubMedGoogle Scholar
• Chang H-Y, Lee P-H, Lei -C-C, et al. Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in Taiwan. PLoS One. 2013;8(4):e61450.23637835
   PubMed Web of Science ®Google Scholar
• Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension. 2006;47(5):962–967. doi:10.1161/01.HYP.0000210550.97398.c216520402
   PubMed Web of Science ®Google Scholar
• Sarrafan-Chaharsoughi Z, Manaviat MR, Namiranian N, Yazdian-Anari P, Rahmanian M. Is there a relationship between body mass index and diabetic retinopathy in type II diabetic patients? A cross sectional study. J Diabetes Metab Disord. 2018;17(1):63–69. doi:10.1007/s40200-018-0339-530288386
   PubMed Web of Science ®Google Scholar
• Zhang GH, Chen HY, Chen WQ, Zhang MZ. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–1595. doi:10.1136/bjophthalmol-2017-31031628855195
   PubMed Web of Science ®Google Scholar
• Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29(3):635–639. doi:10.1161/01.STR.29.3.6359506605
   PubMed Web of Science ®Google Scholar
• Seghieri G, Moruzzo D, Fascerti S, et al. Increase in serum uric acid is selectively associated with stroke in type 2 diabetes. Diabetes Care. 2002;25(6):1095. doi:10.2337/diacare.25.6.1095
   Web of Science ®Google Scholar
• Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke. 2002;33(4):1048–1052. doi:10.1161/hs0402.10592711935059
   PubMed Web of Science ®Google Scholar
• Cui L, Meng L, Wang G, et al. Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study. Mod Rheumatol. 2017;27(6):1066–1071. doi:10.1080/14397595.2017.130011728395604
   PubMed Web of Science ®Google Scholar